63 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2024
-
07/2003 |
48 | Glucose (Dextrose)FDA LinkGeneric
01/2023
-
12/2004 |
47 | LipidsIBA
12/2023
-
01/2002 |
39 | LDL CholesterolIBA
01/2024
-
05/2005 |
36 | oxidized low density lipoproteinIBA
05/2024
-
01/2005 |
31 | CholesterolIBA
11/2022
-
12/2002 |
30 | dapagliflozinIBA
01/2023
-
07/2014 |
26 | Insulin (Novolin)FDA Link
02/2023
-
01/2005 |
21 | Sodium-Glucose Transport ProteinsIBA
01/2023
-
09/2013 |
20 | omega-Chloroacetophenone (Mace)IBA
04/2024
-
01/2018 |
17 | SodiumIBA
01/2023
-
05/2014 |
16 | FructoseIBA
01/2023
-
02/2012 |
15 | Glucagon-Like Peptide-1 Receptor AgonistsIBA
02/2024
-
01/2016 |
15 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2023
-
11/2016 |
15 | Hypoglycemic Agents (Hypoglycemics)IBA
01/2021
-
06/2006 |
14 | Glucagon-Like Peptide-1 ReceptorIBA
02/2024
-
08/2014 |
14 | Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023
-
09/2013 |
14 | Atorvastatin (Lipitor)FDA Link
06/2013
-
01/2003 |
12 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2024
-
06/2005 |
12 | HDL CholesterolIBA
12/2023
-
01/2012 |
12 | semaglutideIBA
01/2023
-
11/2016 |
11 | Biomarkers (Surrogate Marker)IBA
07/2023
-
05/2007 |
10 | ALN-PCSIBA
05/2024
-
01/2017 |
10 | Triglycerides (Triacylglycerol)IBA
03/2024
-
12/2010 |
10 | Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2023
-
01/2008 |
10 | SugarsIBA
01/2023
-
01/2014 |
10 | dulaglutideIBA
10/2022
-
01/2018 |
10 | CreatinineIBA
01/2022
-
01/2012 |
10 | Ezetimibe (Zetia)FDA Link
09/2020
-
01/2003 |
10 | Blood Glucose (Blood Sugar)IBA
10/2018
-
09/2002 |
10 | Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2018
-
06/2005 |
9 | TicagrelorIBA
04/2024
-
05/2019 |
9 | empagliflozinIBA
01/2023
-
10/2019 |
9 | LiraglutideFDA Link
01/2022
-
01/2016 |
9 | Metformin (Glucophage)FDA LinkGeneric
01/2021
-
06/2006 |
8 | rGLP-1 proteinIBA
02/2024
-
08/2014 |
8 | Proteins (Proteins, Gene)FDA Link
11/2022
-
01/2007 |
8 | AlbuminsIBA
01/2022
-
07/2011 |
8 | alirocumabIBA
01/2020
-
01/2017 |
8 | Angiotensin Receptor AntagonistsIBA
01/2018
-
06/2005 |
7 | SymportersIBA
01/2023
-
04/2015 |
7 | 8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
05/2022
-
10/2018 |
7 | Insulin Glargine (Lantus)FDA Link
01/2022
-
10/2013 |
7 | Rosuvastatin Calcium (Crestor)FDA Link
01/2021
-
10/2007 |
7 | Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2016
-
06/2005 |
7 | Valsartan (Vals)FDA Link
12/2013
-
01/2005 |
7 | Nateglinide (Starlix)FDA LinkGeneric
12/2013
-
01/2005 |
7 | 1,4-dihydropyridine (dihydropyridine)IBA
07/2011
-
06/2005 |
6 | (2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
04/2024
-
01/2021 |
6 | Proprotein Convertase 9IBA
12/2023
-
01/2017 |
6 | CarbohydratesIBA
11/2022
-
01/2008 |
6 | saxagliptinFDA Link
11/2021
-
10/2013 |
6 | IncretinsIBA
11/2020
-
02/2010 |
6 | DiureticsIBA
01/2020
-
05/2007 |
6 | CanagliflozinIBA
01/2018
-
09/2013 |
6 | Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2011
-
06/2005 |
6 | ThiazidesIBA
05/2010
-
06/2005 |
5 | ApolipoproteinsIBA
12/2023
-
09/2002 |
5 | HDL LipoproteinsIBA
11/2022
-
11/2012 |